ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0007094;mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1801.8011146821202;6.781341354126479;0.060304661792685066;0.8093530769822879;[PLK1, BUB1B, CENPF, TRIP13, BUB1, MAD1L1, MAD2L1]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[SMARCAL1, CCNH, SMC3, CHEK1, TRIM25, ESCO2, PRKDC, CDCA5, RAD21, BARD1, POLA1, FEN1, BTG2, BRCA1, BRCA2, CHAF1B, CHAF1A, ACTL6A, PARP9, SIRT1, RAD51C, PCNA, UNG, RAD54B, USP1, RAD54L, APBB1, PMS1, GINS2, RPA1, GTF2H1, MLH1, RPA3, TRIP13, DCLRE1A, RUVBL2, RUVBL1, MEN1, LIG1, MSH6, MSH2, FANCD2, TIMELESS, BLM, RNASEH2A, PSMD14, FANCI, HMGA1, ISG15, FANCG, COPS5, JMY, CDK1, FOXM1, EXO1, TOPBP1, RFC5, RFC3, RFC4, RFC1, RFC2, H2AFX, SMC1A, DTL, UHRF1, POLD3, CDC45, POLD1, RBBP8, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, RAD50, RAD51, POLE2]
GO:0007095;mitotic G2 DNA damage checkpoint;11.0;1.0;0.9324289523296623;9.628524252492122;857.7571147403349;6.7325511899570465;0.028708358699073767;0.7767319332797141;[MSH6, FANCI, BLM, DONSON, CDK1, TOPBP1]
GO:0035563;positive regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.32148238131123;7.292166977892469;0.0010483018277984315;0.6631627702307852;[CDT1, GMNN, PARP9]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, PLK1, CETN3, CEP120, HEPACAM2, TUBE1, BRCA1, CKAP5, UXT, FES, NUP62, CDK1]
GO:0007099;centriole replication;6.0;1.0;0.8231203125901445;9.628524252492122;79.09414177220606;6.781341354126479;0.0026472097450095456;0.6699184248047958;[PLK4, CEP152, CEP72]
GO:0033262;regulation of nuclear cell cycle DNA replication;9.0;0.7140352122741334;0.7532582313173557;9.240758721483358;171.6907107923128;7.212124270218933;0.00574633357861074;0.7650689957573628;[CDT1, DACH1, BCL6]
GO:0046578;regulation of Ras protein signal transduction;8.0;0.6954798709641801;0.72273993548209;8.712233520617966;46.45640819702609;4.388001897863968;0.0015548541743014947;0.5994026211197198;[EPS8, ARHGDIA, STMN1, ARHGDIB, EPHB2, PDGFRB, F2R, TIAM2, RASAL2, RASGRP1, RASGRP4, ECT2, ABCA1, TGFB2, IGF1, BCL6, GPR18, NRP1, KIF14, ARHGEF10L, ARRB1, FOXM1, NUP62, PSD3, TIMP2, RALGPS2, PLEKHG1, ARHGEF12, GPR35, ARAP3, VAV1, DNM2, FBP1, FGD3, FGD4, EPS8L1, EPS8L3, COL3A1, DLC1, F2RL1, F2RL3]
GO:1903126;negative regulation of centriole-centriole cohesion;10.0;1.0;0.9152410118609203;9.628524252492122;269.77484522762467;9.777073627680469;0.009029121288170608;0.9152410118609203;[NEK2]
GO:0007019;microtubule depolymerization;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;92.92880478075006;7.004484905440688;0.003110243465517153;0.7091290490632969;[KIF18A, STMN1, KIF2C, CKAP5]
GO:0000212;meiotic spindle organization;7.0;0.7671156992804218;0.7344772148974115;9.168991923113682;69.6769368299192;7.292166977892469;0.002332024370525413;0.7238411236270654;[ASPM, FBXO5, TUBG1]
GO:0110032;positive regulation of G2/MI transition of meiotic cell cycle;9.0;1.0;0.896240625180289;9.628524252492122;414.4836470731219;8.67846133901236;0.013872394656472954;0.8400575416471059;[CDC25C, CDC25A]
GO:0071373;cellular response to luteinizing hormone stimulus;8.0;1.0;0.875;9.628524252492122;601.1788189541068;8.67846133901236;0.020120914044583264;0.8188169164668168;[CCNA2, LHCGR]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, IGF1, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, IGF1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0044320;cellular response to leptin stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.379178354882098;0.003661012767841448;0.7004918368257019;[CCNA2, PID1, NR4A3]
GO:0034501;protein localization to kinetochore;8.0;0.8436909121759173;0.7968454560879586;9.292052015870908;35.81813124301707;7.212124270218933;0.0011988006184784857;0.7438283705770736;[MIS12, CDK1, BUB1B, AURKB]
GO:0090502;RNA phosphodiester bond hydrolysis, endonucleolytic;8.0;0.6799073451904818;0.7149536725952409;8.878218658092228;231.13671471601307;5.395046993006588;0.007735937832006836;0.6509029541176994;[POP5, FEN1, RNASEH2A, EXO1, RNASE2]
GO:0090344;negative regulation of cell aging;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;80.6841056931466;6.686031174322154;0.002700424406568797;0.6321649570480018;[PRKDC, PLK2, TWIST1, MIF, SLC30A10, FOXM1, SIRT1, CDK6, BCL6]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, MCTS1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, NCF1, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, G3BP2, CXCL12, DMXL2, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC2, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CDC45, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, RXRA, CCT8, CD74, GCH1, RPA1, RPA3, NDUFAB1, TGM2, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, LPXN, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, CLINT1, TK1, BRD2, HCLS1, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, SYNJ1, CDK1, PIK3C2A, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, CDT1, AHCTF1, HBZ, RAD51C, UQCR10, AIF1, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, CKAP5, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, RBMX]
GO:0036120;cellular response to platelet-derived growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.781341354126479;0.003262744749111514;0.6699184248047958;[PDGFRB, CCNA2, PDGFD, FYN]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[HDAC2, ARG1, CAD, NME1, ICAM1, NR4A2, CDK1, DRD4]
GO:0007020;microtubule nucleation;6.0;0.7980440201809971;0.722142322680643;9.0689084645567;33.1981629444775;6.686031174322154;0.0011111126373447525;0.665044257777226;[CETN3, TUBG1]
GO:0030261;chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.223059144383958;23.949217433387346;6.343086423195323;8.01558754599117E-4;0.6753050999230941;[TOP2A, CDCA5, NCAPG2, SMC4, NCAPH, SMC2, CDK1, ACIN1, NCAPD2, NCAPD3]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, DNMT1, IQGAP3, RASGRP1, G3BP2, JUN, HACE1, PLK2, DHCR24, IGF1, COL1A2, BCL6, LAT, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, RNASEH2A, LIG1, RPA1, MLH1, MSH6, POLD3, MSH2, EXO1, RPA3, PMS1]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[CALML4, UXT, CDC20, STMN1, FBXO5, MAP1B, KIF20A, LLGL2, PRKCZ, FIGNL1, CEP72, PLK2, PLK1, PTK2, CETN3, KIF11, NUF2, TUBG1, KIF2C, CENPA, FLNA, RANBP2, RANBP1, TUBE1, CENPE, SPC25, CEP120, NEK2, GAS2L3, MAP7D1, MAP7D2, CCNB1, STIL, NEK7, NDC80, KIF18A, FES, KIF4A, CDK1, NAV1, CKAP5, ASPM, PSRC1, BIRC5, BIRC2, BIRC3, VPS4B, AURKB, WEE1, PRC1, RAN]
GO:0000076;DNA replication checkpoint;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;54.456905800140625;6.8867018697843045;0.0018226236290973575;0.7271862538851576;[CDT1, CDC45, TIMELESS, CDC6, TOPBP1, NAE1]
GO:0001556;oocyte maturation;4.0;1.0;0.75;9.628524252492122;79.08984218955116;6.8867018697843045;0.0026470658418474595;0.6021862538851576;[CCNB1, FBXO5, TRIP13, BRCA2, EREG]
GO:0045143;homologous chromosome segregation;5.0;1.0;0.7902410118609202;9.628524252492122;44.56456858672447;7.697632086000634;0.00149153600508981;0.6838982747154925;[PLK1]
GO:0000070;mitotic sister chromatid segregation;6.0;1.0;0.8231203125901445;9.628524252492122;56.84344269090966;6.311337724880743;0.0019024988710876387;0.6458824173477649;[MIS12, PLK1, CDCA8, SMC1A, TUBG1, SMC4, ZWINT, NDC80, KIF18A, NEK2, RAN, MAD2L1]
GO:0033762;response to glucagon;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;6.166155715036245;0.0024778305216419678;0.6662568552797195;[ARG1, ABCB4, GLP2R, CCNA2, ADCY9, PRKAR1B, RPS6KB1, PRKAR2B, CYC1, PRKACB]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[CDKN1A, CEBPB, PCNA, C5AR1, IHH, ADM, TYMS, ATIC, HMOX1, IL10, MED1, TGFB1, ANXA3, CAD, SULF2, TGFBR3, NFKBIA, CCNA2, CXCL12, NR4A3, CDK1, LCP1, EZH2]
GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;11.0;0.8259837884571596;0.845420846558242;9.498471124243924;3778.5456327194074;5.334422371190153;0.12646452185682636;0.705231560468336;[LRRK2, CLU, AKT1, CBFA2T3, RNF144B, TRIB1, CEBPA, IL33, PLK2, CAV1, PLK1, DAB2]
GO:2001178;positive regulation of mediator complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;9.083926447120524;0.004698449899916962;0.8154717862087246;[CDT1]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CCNB1, IL1B, FMR1]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, ICAM1, LGALS1, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, STAT1, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, PDE4D, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, HDAC2, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5, RPS6KB1]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[PPP2R1A, NEK2, CDC25C, CDC25A, MSH6, BLM, CCNB1, PRKAR2B, RAD21, CEP72, NAE1, CEP76, FANCI, PLK4, PLK1, CDC6, CDK6, CDK1, KIF14, BRCA1, TOPBP1, TUBG1, CKAP5, RAD51C, DTL, SMARCD3, VPS4B, AURKB, CEP152, DONSON, CENPF]
GO:0090435;protein localization to nuclear envelope;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;34.85305034697331;7.697632086000634;0.0011665002294043187;0.7445766281117727;[NUP155, PLK1, NUP54]
GO:0007077;mitotic nuclear envelope disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;74.08347249058063;7.292166977892469;0.002479507153463127;0.6960420709600095;[CCNB2, CCNB1, PRKCB, PLK1, CDK1, VRK1]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[CHEK1, SLBP, BLM, RNASEH2A, BARD1, CDT1, CDC6, POLA1, POLA2, NASP, CDK1, ACHE, FEN1, MCM7, BRCA1, CHAF1B, CHAF1A, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, RMI1, DBF4, MCM3, MCM4, MCM6, DTL, MCM2, CDC45, POLD1, RBBP8, RRM1, RRM2, RPA1, DONSON, RAD50, POLE2, RPA3, DNAJA3, SSBP1]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[NEK7, PRKCQ, NEK2, AURKB]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, CCNC, PHB2, CHEK1, AKT1, SOX4, MED1, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, CDCA5, TGFA, RACGAP1, RAD21, SFN, PLK4, CDT1, PLK2, CDC6, IGF1, CD28, CDKN1A, FEN1, BTG2, KIF14, BRCA1, BRCA2, IL10, EDN1, ANXA1, DUSP3, CIT, IL1A, RAD51C, TAL1, IL1B, CKS2, RARA, PLCB1, PCNA, CXCR5, KCNA5, AIF1, RANBP2, RANBP1, SVIL, POU4F1, FAP, MAD2L1, CCNT2, CEP120, CTGF, PDGFRB, CDC25C, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK1, NUP62, CASP2, CCNA2, PSRC1, TFDP1, DTL, SMARCD3, VPS4B, AURKB, CDC45, E2F1, E2F7, SH2B1, E2F8, EGF, MEIS2, PML, RPS6KB1, EVI2B]
GO:1905448;positive regulation of mitochondrial ATP synthesis coupled electron transport;12.0;0.9326813400603323;0.9144609826203107;9.600353375525426;1375.5648477489242;8.390779266560578;0.04603891752616661;0.8772251544931927;[CCNB1, CDK1]
GO:0046599;regulation of centriole replication;10.0;0.8259837884571596;0.8282329060895002;9.503361109538115;89.11396308082499;6.943860283624253;0.002982564146955293;0.7703503496879909;[PLK4, STIL, PLK2, VPS4B, NUP62, BRCA1, CEP76]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0001890;placenta development;4.0;1.0;0.75;9.628524252492122;49.86610466882393;6.193554689224359;0.0016689736466849693;0.5667386748366816;[ABCB4, HTRA1, MAPK14, ASCL2, PTK2, DCN, PHLDA2, E2F7, BIRC2, E2F8]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, BCL3, HLA-DQB1]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[IL10, ABCB4, POU4F1, CCNA2, KIF18A, RUVBL2]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, JUNB, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, NME1, IL1B]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[PLK4, LIF, NR2F2, E2F7, E2F8]
GO:0051383;kinetochore organization;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;38.75571468247735;6.8867018697843045;0.0012971188925437662;0.6424272657460779;[CDT1, MIS12, SMC4, CENPA, NDC80, SMC2, CENPE, CENPF, CENPH, CENPK, NUF2, CENPN]
GO:0000281;mitotic cytokinesis;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;28.615093046006976;5.649939242635378;9.577214123380678E-4;0.5791791674783379;[BRCA2, CENPA, RACGAP1, STMN1, ECT2, MYH10, CEP55, CDT1, PLK1, CKAP2, CIT, KIF4A, KIF20A]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PRKDC, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, IGF1, PML, EREG, BTC, CCNA2, CDK6, NDUFS4]
GO:2000377;regulation of reactive oxygen species metabolic process;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;26.78229071161683;4.7018998124466425;8.963791676210415E-4;0.5306963869301438;[PID1, HP, TNF, CLU, ICAM1, AKT1, CYP1B1, CD177, PDGFRB, PRKCD, AGTR1, FPR2, SLC30A10, FOXO1, KLRK1, TGFB1, AGXT2, CAV1, BST1, BCL2, NOX4, CDKN1A, ITGAM, ITGB2, BRCA1, FOXM1, RAC2, CD36, CD34, IL10, EDN1, SYK, PAX2, DNM2, IFNG, IL1B, TLR6, TLR4, BIRC2, PTGS2, THBS1, AIF1, GNAI2, SNCA, GCH1, MAPK14, KLF4, F2RL1, PTX3]
GO:0071314;cellular response to cocaine;7.0;1.0;0.8509193652572005;9.628524252492122;537.09778937307;8.67846133901236;0.017976179653688387;0.7947362817240173;[CCNA2]
GO:2000775;histone H3-S10 phosphorylation involved in chromosome condensation;12.0;1.0;0.9481203125901445;9.628524252492122;711.4828594708514;9.777073627680469;0.023812691013487215;0.9481203125901445;[CCNB1]
GO:0014038;regulation of Schwann cell differentiation;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;65.83981520803086;8.67846133901236;0.0022035993630260702;0.8400575416471059;[CDK1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, USP18, FAM105A, USP1, IL33, USP9Y, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0007088;regulation of mitotic nuclear division;7.0;0.5860072649471136;0.6439229977307573;8.169909229792605;54.97351338155213;4.573066940603674;0.0018399140199305624;0.5847862212690335;[BUB1B, SMC3, PHB2, CHEK1, KNTC1, NEK2, FBXO5, PDGFRB, CDC25C, EREG, BTC, CCNE2, CCNE1, AURKAIP1, MAD1L1, CDCA5, TGFA, PKMYT1, CCNB2, CCNB1, RAD21, CDT1, TGFB1, CAV2, UBE2C, PLK1, CDC6, IGF1, NDC80, STAG2, CD28, KIF11, NUP62, EDN1, DUSP1, SMC1A, CCNA2, IL1A, IL1B, VPS4B, BUB1, SH2B1, RANBP2, RANBP1, EGF, CENPE, CENPF, TRIP13, MAD2L1]
GO:0090166;Golgi disassembly;5.0;1.0;0.7902410118609202;9.628524252492122;58.9131161342151;7.9853141584524145;0.001971768978649902;0.6986103492792611;[CDK1, VRK1]
GO:0010923;negative regulation of phosphatase activity;9.0;0.7866048967936545;0.7895430735771163;9.362821086759116;265.75489588375854;5.142344639450834;0.008894577201350937;0.659220369185286;[PLEKHF2, PLEKHF1, TNF, PPP1R12A, MASTL, PPP1R15A, PKMYT1, GNAI2, NCKAP1L, TGFB2, FKBP1B]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[CCNA2, GHSR, TGFB1, FBN1]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, PRKDC, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, GADD45B, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, FOXM1, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0031442;positive regulation of mRNA 3'-end processing;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;630.6357977915417;7.57984905034425;0.021106812616712402;0.8028748447945538;[CCNB1, NCBP2]
GO:0010800;positive regulation of peptidyl-threonine phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;778.6672313762616;6.375876246018314;0.026061291479152104;0.7413036195908642;[TGFB1, EGF, RIPK2, PLK1, AZU1, CHI3L1, CALM3]
GO:2000781;positive regulation of double-strand break repair;9.0;0.8933024483968273;0.8428918493787028;9.55953138100517;610.2987732095577;6.943860283624253;0.020426150706087248;0.7513499630073597;[BLM, TIMELESS, PARP9, FOXM1]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[SEH1L, CDCA5, VPS4B, KIF14, CDCA8, CCNB1, NUP62, CENPE, KIF18A, PSRC1, KIF2C]
GO:0051315;attachment of mitotic spindle microtubules to kinetochore;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;27.921945865447032;7.379178354882098;9.345223999966889E-4;0.6273715242355574;[CENPE, CDT1, SEH1L, MIS12, NUF2, KIF2C, NDC80, MAD1L1]
GO:0090656;t-circle formation;8.0;1.0;0.875;9.628524252492122;168.69220570471313;7.379178354882098;0.005645976311808157;0.7523715242355574;[SMARCAL1, BLM, EXO1]
GO:0072708;response to sorbitol;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;29.400638164542393;8.16763571524637;9.840129005107402E-4;0.7079342821725234;[CDT1, MAP2K6, MAPK13]
GO:1905342;positive regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;8.390779266560578;0.002466909593039506;0.7800242071602487;[CDT1, NDC80]
GO:0007051;spindle organization;6.0;0.6873818243518346;0.6668112247660618;8.690254613899192;44.522636097919765;4.786641040901733;0.0014901325624263064;0.5679093580234316;[CEP120, KIF11, CDC20, STMN1, NUF2, NEK2, FBXO5, TUBG1, CKAP5, ASPM, BIRC5, BIRC2, BIRC3, AURKB, CCNB1, FLNA, CEP72, RANBP2, RANBP1, STIL, PLK2, NEK7, NDC80, CENPE, KIF4A, RAN, SPC25]
GO:0060045;positive regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;720.414482973016;6.641579411751319;0.024111624414165377;0.7548916918429109;[TGFBR3, MEF2C, CCNB1, CDK1, MAPK14]
GO:1905341;negative regulation of protein localization to kinetochore;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;9.777073627680469;0.0024696432832320894;0.8509193652572005;[CDT1]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[KIF11, AURKB, CDC20, CCNB1, STMN1, NUF2, FLNA, NEK2, STIL, PLK2, TUBG1, NDC80, CENPE, KIF4A, BIRC5, RAN, BIRC2, SPC25, BIRC3]
GO:1904779;regulation of protein localization to centrosome;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;29.0551629072873;7.57984905034425;9.724501545579579E-4;0.710754145523778;[NUP62, CEP72]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[CTGF, FGF5, FLRT2, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, NCBP2, SHCBP1, KIF16B, ESRP1]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA, SLA2, GRAP2, AKT1, NEK2, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, MATK, VRK1, MELK, BTK, SIK1, BLK, CSF1R, TXK, THY1, LYN, EIF2AK2, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, JAK3, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0051445;regulation of meiotic cell cycle;5.0;0.5498737448241444;0.5651778842729924;7.5284634236095505;25.888472835594534;5.8650506222523235;8.664638876944386E-4;0.5901799734356507;[BRCA2, CDC20, PPP2R1A, FBXO5, PRKACB, DUSP1, LIF, CDC25C, CDC25A, ASPM, MSH2, CDK1, TRIP13, PLCB1]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[SP100, HDAC2, LEF1, GATA1, E2F1, HMOX1, NEK2, JUN, GZMA, NFKBIA, ID1]
GO:0098535;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;68.46281579932104;8.16763571524637;0.00229138883226928;0.7686126355688037;[PLK4, CEP152]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[HHEX, ANXA1, HNF1B, E2F7, E2F8]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CCNA2, FOXO1, DNM2, AQP1]
GO:0072425;signal transduction involved in G2 DNA damage checkpoint;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;196.6208089386036;7.292166977892469;0.006580721527935406;0.769162383550154;[CHEK1, PLK1, BRCA1, DTL]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCB, PRKCD, VRK1, AURKB, CCNA2, CCNB1, CHEK1, CDK1, PKN1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, E2F1, HMOX1, FABP1, BCL2]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[SMARCD3, VPS4B, CDC25C, CDC25A, CCNB1, RAD51C, CDK1, DTL]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, MED1, PRKCD, PARP9, IFNG, HCLS1, PTGS2, FYN, CCT8, CCT7, ECT2, CCT5, CCT4, TGFB1, JUP, PLK1, LIF, IGF1, MAPK14, CCT6A, CDK1]
GO:0007062;sister chromatid cohesion;5.0;0.7508913569872202;0.6656866903545304;8.801845679307654;32.565640385727406;6.113511981550823;0.001089942676536732;0.6028862989048107;[CDCA5, PLK1, BUB1B, ESCO2, SMC1A, SMC3, PHB2, CDC20, RAD51C, STAG2, PPP2R1A, RAD21, BUB1]
GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2922.0785093664276;6.193554689224359;0.09779933800857048;0.7648589874268262;[CCNT2, CCNH, CCNC, CCNB1, AKT1, CDC6, PSRC1, CKS2]
GO:0000706;meiotic DNA double-strand break processing;8.0;0.8933024483968273;0.8216512241984136;9.533214072687796;173.9732844268755;7.9853141584524145;0.005822729263976651;0.7833693374183408;[BLM, EXO1]
GO:1901673;regulation of mitotic spindle assembly;10.0;1.0;0.9152410118609203;9.628524252492122;218.77880646863287;6.832634648514029;0.0073223297643623805;0.7646622655359331;[VPS4B, PLK1, SMC1A, SMC3, STAG2]
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;12.0;0.8653626801206646;0.8808016526504769;9.548481544818586;280.44081179639056;7.138016298065211;0.009386101590480495;0.8131587980249038;[CDT1, CCNB1, DUSP1, NDC80, MAD2L1]
GO:0007344;pronuclear fusion;6.0;1.0;0.8231203125901445;9.628524252492122;29.37726267204044;9.777073627680469;9.832305438132773E-4;0.8231203125901445;[CDK1]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[CDC20, UBE2C, PLK1, MASTL]
GO:0046785;microtubule polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;97.26999823215544;7.292166977892469;0.0032555393035152377;0.7238411236270654;[FBXO5, CKAP5]
GO:0045736;negative regulation of cyclin-dependent protein serine/threonine kinase activity;12.0;0.8933024483968273;0.8947715367885583;9.585964638073326;2927.1185870500644;6.375876246018314;0.09796802487286638;0.7741829203200885;[CEBPA, CDKN1A, MYOCD, CDKN2C, PLK1, TNFAIP3, NR2F2, HHEX, CDK6, MEN1]
GO:0071163;DNA replication preinitiation complex assembly;7.0;0.8653626801206646;0.7836007053175329;9.387362195675234;77.2272886234996;8.67846133901236;0.002584727850181096;0.7947362817240173;[CDT1, CDC45, GMNN]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[EHF, LGALS3, BASP1, AKT1, HOXA5, SOX4, MEN1, MED1, MEF2C, HNF1B, EREG, COL4A1, ADAM9, HOXB5, EPHA2, GATA3, PSAP, FZD1, ST14, JUN, TGFB1, JAG1, VIL1, FA2H, BMP2, DAB2, CDK1, CD24, TGFB1I1, SLC7A11, TMEM100, HHEX, LBH, CD34, CTSB, DSP, ANXA1, PAX2, GREM1, ELF3, TST, RARA, FAM20C, YAP1, TAGLN, CEBPB, CSTA, HDAC2, PCNA, LEF1, RXRA, E2F7, E2F8, CDX2, KLF4, USH2A, GRHL2]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, STAT1, CENPF, LGR4, GMNN, CTGF, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, FOXM1, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, UHRF1, E2F1, FYN, E2F7, E2F8, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RELB, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, NCBP2, GREM1, ELF3, IRF7, IRF8, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, NEDD4L, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, HAVCR2, PAWR, PAX5, PAX2, AES, TAL1, RARA, GAS1, HCLS1, PLCB1, ENG, NR1I2, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, DNMT1, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, HBZ, EDN1, PARP9, CBFA2T3, NME1, MDFIC, SP100, TYMS, AIF1, PURA, APBB1, CDX2, MLH1, LILRB4, ARID4A, CHCHD3, BASP1, TIMELESS, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, NEK2, CCT4, CCT2, NEK7, KLF4, GRHL2, GREM1, PRKCQ]
GO:0070194;synaptonemal complex disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;39.82835148474282;9.083926447120524;0.0013330190810051427;0.7876727335416686;[PLK1]
GO:0071283;cellular response to iron(III) ion;7.0;1.0;0.8509193652572005;9.628524252492122;96.28817659807011;9.083926447120524;0.003222678617004505;0.8154717862087246;[CCNB1]
GO:0071168;protein localization to chromatin;7.0;0.7369933605727446;0.7194160455435727;8.935377071932177;34.71951895434896;6.832634648514029;0.001162031053863633;0.7003406189322132;[RUVBL2, RAD21, PLK1, ESCO2, EZH2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, FOXM1, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, IGF1, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DNMT1, DAB2, COPS5, MAFB, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0060718;chorionic trophoblast cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.6676932703116032;[FZD5, HTRA1, E2F7, E2F8]
GO:0031145;anaphase-promoting complex-dependent catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;350.55619955642163;6.221725566191056;0.011732800519056534;0.7334203466557586;[BUB1B, AURKB, CDC20, CCNB1, UBE2C, PLK1, CDK1, MAD2L1]
GO:0033566;gamma-tubulin complex localization;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.77205030767364;9.083926447120524;0.001364603831334836;0.7876727335416686;[CEP72]
GO:0032873;negative regulation of stress-activated MAPK cascade;11.0;0.8436909121759173;0.8542744084176208;9.56534535087059;1526.0559120613332;6.039404009397101;0.051075718015538125;0.7412843542312382;[PTPN22, FOXM1, FOXO1, DUSP10, AKT1, MEN1, DUSP3, SFRP2, F2RL1, ZMYND11]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, CDK1, FHL2, MYH10]
GO:0016321;female meiosis chromosome segregation;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;64.47658740127405;8.390779266560578;0.0021579733551592936;0.7193458537639684;[PLK1, MLH1]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0032877;positive regulation of DNA endoreduplication;10.0;1.0;0.9152410118609203;9.628524252492122;1140.1023815324472;9.083926447120524;0.03815820068436285;0.8797934328124444;[E2F7, E2F8]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, PRKDC, NEDD4L, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, UBR1, SOCS2, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, UBE2Q2, HIST1H2BK, RNF6]
GO:0090307;mitotic spindle assembly;8.0;1.0;0.875;9.628524252492122;186.05212215721153;6.193554689224359;0.006226997092562797;0.6917386748366816;[KIF11, CDC20, FLNA, BIRC5, NEK2, BIRC2, BIRC3]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, SELPLG, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[MED1, IFNG, LRRK2, CDK1, IGF1]
GO:0030174;regulation of DNA-dependent DNA replication initiation;9.0;0.7508913569872202;0.7716863036738992;9.326243380619188;154.23465726608282;7.9853141584524145;0.005162095176516053;0.8046099625986299;[CDT1]
GO:0045740;positive regulation of DNA replication;8.0;0.7671156992804218;0.7585578496402109;9.427853557029971;747.3070825002359;6.166155715036245;0.025011695518573164;0.6903374900225189;[CDT1, JUN, PCNA, EREG, CST3, DBF4, CDK1, E2F7, E2F8]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[, SLA2, MYLK, AKT1, PRKACB, MEF2A, MED1, MEF2C, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, PRKAR1B, PRKCQ, PRKDC, PDGFA, THY1, IQGAP3, PRKCZ, LYN, PLK4, PLK2, PLK1, EIF2AK2, CDK14, ITK, JAK3, RIPK2, DUSP6, CIT, RARA, HBEGF, NRAS, IL12RB2, GTF2H1, PKN1, CCNT2, IL5RA, SLA, TNF, FGF5, EFEMP1, GRAP2, MAP3K8, NEK2, STK32B, KCNH1, MEN1, KCNH2, MAP2K2, IGFBP3, VRK1, NRBP1, MELK, BLK, CSF1R, RASAL2, PKMYT1, MAP2K6, NEK7, BMX, NFKB1, CDK6, CDK1, BCL2, LAT, LRRK2, PIK3CD, TLK1, CHUK, SPTB, LCK, IL3RA, BIRC5, PIK3C3, NOD2, IL2RG, CCL8, CCL5, CCL2, FYN, CSK, TIE1, PML, IL2RB, PTPN6, CCNH, CCNC, CHEK1, RPS6KA1, TNFSF11, EPHB2, EPHB1, PAQR3, EREG, BTC, BTK, SIK1, ALPK2, TRIB1, EPHA3, EPHA2, TXK, LIF, IGF1, PTK2, CTSH, CTSG, CCR5, SPTAN1, MAP4K1, SYK, STRADB, IL18, GFRA3, HCK, IL1B, KIT, FAM20C, TLR7, SGK1, TLR4, TLR2, GUCY2C, PAK1, PRKY, KITLG, CAMK4, CAMK1, BUB1B, PDGFRB, PDGFRA, MATK, CCNE1, CSF2RB, CSF2RA, RASGRP1, RASGRP4, SPTA1, CCNB1, TGFB2, TGFB1, EIF2S1, CLK4, CLK1, BMP2, FES, GHR, CAD, IRAK3, MASTL, TGFBR3, FGR, CCNA2, ZAP70, SHANK3, CAMK2D, AURKB, NCAM1, BUB1, EGF, MAPK14, MAPK13, WEE1, RPS6KB1, TEK]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, TNFAIP3, CCNC, HERC5, HHEX, AKT1, MEN1, MYOCD, CDC25C, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, CEBPA, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2, CDK6]
GO:0060623;regulation of chromosome condensation;7.0;0.8259837884571596;0.7639112594857803;9.377209824211215;21.750886949199476;8.390779266560578;7.279826116623381E-4;0.7800242071602487;[CCNB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;8.0;1.0;0.875;9.628524252492122;145.46952913610525;7.004484905440688;0.004868734226108882;0.7332096838060964;[CDKN1A, SP100, BRCA1, BRCA2, FOXM1]
GO:0046680;response to DDT;5.0;1.0;0.7902410118609202;9.628524252492122;46.407574972267774;9.777073627680469;0.0015532197702158826;0.7902410118609202;[CCNB1]
GO:0051225;spindle assembly;7.0;0.7508913569872202;0.7263650437508107;9.168991923113682;86.84099814437;5.266214121163619;0.00290649005606778;0.6202338003175094;[KIF11, CDC20, FLNA, NEK2, FBXO5, NEK7, TUBG1, ASPM, BIRC5, BIRC2, BIRC3]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, TYMS, CCL7, CNR1, FYN, CD14, GSN, VCAM1, GGH, RPS6KB1, CDK1, CD27]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, FOXM1, PPP2R1A, NEK2, SKP2, TUBG1, MASTL, CDC25C, CKAP5, CDC25A, CIT, DNM2, CCNA2, MELK, PLCB1, PKMYT1, CCNB2, CCNB1, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, WEE1, CDK1, CDK14]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[CDKN1A, BTG2, PCNA, CCNB1, E2F1, CASP2, SFN, E2F7, SOX4, E2F8, PLK2, CDC25C, PML, TFDP1, CNOT3, CDK1]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[CDT1, PCNA, RRM2, GFI1, CDC6, TYMS, POLA1, TFDP1, CDC45, CCNE1, E2F1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, MCM7, GMNN, SKP2, CDC25A, DBF4, CDC34, CCNE2, CCNE1, MCM3, MCM4, RHOU, MCM6, BCAT1, MCM2, CUL5, PRIM1, IQGAP3, GSPT1, CDC45, RBBP8, RANBP2, RANBP1, CDT1, CDKN2C, PLK2, RPA1, CDC6, INHBA, POLA1, POLA2, WEE1, CDK6, NASP, RPS6KB1, POLE2, RPA3]
GO:0032465;regulation of cytokinesis;6.0;0.5930994877375815;0.6196700564589352;8.140447197062288;31.798591743249187;5.358233019883872;0.0010642702487719462;0.5971405984103235;[AHCTF1, KIF14, BRCA2, NUP62, PRKCE, TAS2R13, CIT, PIK3C3, KIF20A, CXCR5, AURKB, RACGAP1, ECT2, E2F7, E2F8, SVIL, PLK1, CDC6, PRC1, CALM3, BCL2L1]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MAPK13, MFAP4, NEDD4]
GO:0032466;negative regulation of cytokinesis;7.0;0.7140352122741334;0.7079369713942671;9.015419779605713;142.53412634803104;7.8311634786251565;0.004770488936483034;0.7514054297404357;[E2F7, AURKB, E2F8]
GO:0050658;RNA transport;7.0;0.6393367784920305;0.6705877545032157;8.391761625343195;40.09103529276204;4.488806596985934;0.0013418108716594672;0.5804771433779154;[, NUP107, FMR1, MAGOH, SLBP, NUP205, SEH1L, NUP160, NUP85, G3BP2, NUP88, NUP155, UPF3B, AHCTF1, HHEX, XPO1, NUP62, NUP133, NCBP2, CKAP5, TST, NUP54, NUP43, RANBP2, RANBP1, MX2, NUP35, NUPL2, RAN, NUP37]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0051987;positive regulation of attachment of spindle microtubules to kinetochore;7.0;0.8653626801206646;0.7836007053175329;9.485423408851448;141.20478198009135;8.16763571524637;0.004725996976820352;0.7686126355688037;[CCNB1]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, CDC25C, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4]
GO:0051988;regulation of attachment of spindle microtubules to kinetochore;6.0;0.7763722522362496;0.7113064387082693;9.271849308553389;31.575448191934637;7.212124270218933;0.0010568018349256063;0.6919486831672181;[CCNB1, RACGAP1, NEK2, ECT2]
GO:0045190;isotype switching;12.0;0.8259837884571596;0.8611122068187244;9.517298617381897;267.39842152832483;6.943860283624253;0.00894958452559752;0.8032296504172152;[MLH1, HSPD1, MSH6, CD40LG, MSH2, EXO1, CCR6]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, FOXM1, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, DNMT1, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, TIMELESS, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[IL1RN, CELSR1, HNF4A, PHLDA2, PRKACB, IL10, HNF1B, DUSP6, SFRP2, PLCB1, LAMA2, LAMA4, LAMA3, GATA3, DLL1, GATA1, RACGAP1, FZD1, CDX2, CDX1, IGF1, KLF4, SULF1, COL5A1, COL5A2, CDK1, FOXA2]
GO:0046601;positive regulation of centriole replication;11.0;0.9326813400603323;0.8987696223598284;9.592156608321247;492.4861511887348;8.67846133901236;0.016483068271526433;0.8762458687964789;[PLK4, VPS4B, NUP62]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[POSTN, GSN, GPX1, TXK, CCNB1, NINJ1]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:1902426;deactivation of mitotic spindle assembly checkpoint;13.0;1.0;0.9625549647676366;9.628524252492122;1950.7008717452545;9.777073627680469;0.0652882026605069;0.9625549647676366;[CDT1]
GO:0046602;regulation of mitotic centrosome separation;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;111.3333211242262;7.212124270218933;0.003726226064543951;0.7650689957573628;[RANBP2, RANBP1, CHEK1, NEK2, KIF11]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[PLK1, NAV1, PSRC1, FES, PRC1, MAP1B, KIF20A]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[PPP2R1A, NEK2, TUBG1, CKAP5, PRKAR2B, CEP72, CEP76, PLK4, CEP152, PLK1, CDK1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[AURKB, NEK2, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, NEK7, CCT6A, PRKCQ]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[VPS4B, CEP120, FIGNL1, TUBG1]
GO:2000105;positive regulation of DNA-dependent DNA replication;9.0;0.7763722522362496;0.7844267512984139;9.440472020989182;901.5417397663175;7.379178354882098;0.03017379069508918;0.7736121494158466;[CDT1, E2F7, E2F8]
GO:0030951;establishment or maintenance of microtubule cytoskeleton polarity;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;65.29771360028688;8.390779266560578;0.002185455710074652;0.7522251544931926;[KIF2C, CKAP5]
